Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00MNG
|
|||
| Former ID |
DNCL003020
|
|||
| Drug Name |
HIV gp41 vaccine
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 1 | [1], [2], [3] | |
| Company |
Mymetics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01084343) Investigation of the Safety of an HIV-1 Vaccine Given Intra-muscularly and Intra-nasally to Healthy Female Subjects. U.S. National Institutes of Health. | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021858) | |||
| REF 3 | Clinical pipeline report, company report or official report of Mymetics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.